Revenue - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Revenue Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Revenue
ÂŁ31.4B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
A
AstraZeneca PLC
NASDAQ:AZN
Revenue
$49.1B
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Revenue
$1.1B
CAGR 3-Years
17%
CAGR 5-Years
4%
CAGR 10-Years
0%
Hikma Pharmaceuticals PLC
LSE:HIK
Revenue
$3B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
7%
Allergy Therapeutics PLC
LSE:AGY
Revenue
ÂŁ53.3m
CAGR 3-Years
-13%
CAGR 5-Years
-6%
CAGR 10-Years
3%
Dechra Pharmaceuticals PLC
LSE:DPH
Revenue
ÂŁ761.5m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
15%

GlaxoSmithKline PLC
Revenue Breakdown

Breakdown by Geography
GlaxoSmithKline PLC

Total Revenue: 30.3B GBP
100%
United States: 15.8B GBP
52.2%
Rest Of World: 13.8B GBP
45.6%

Breakdown by Segments
GlaxoSmithKline PLC

Not Available

See Also

What is GlaxoSmithKline PLC's Revenue?
Revenue
31.4B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Revenue amounts to 31.4B GBP.

What is GlaxoSmithKline PLC's Revenue growth rate?
Revenue CAGR 10Y
3%

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for GlaxoSmithKline PLC have been 1% over the past three years , and 3% over the past ten years .

Back to Top